Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Testagen, 20mg
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
Testagen is a short peptide bioregulator belonging to the Khavinson peptide class. It is investigated for its proposed interactions with chromatin-associated regulatory systems, transcription-associated processes, and peptide-mediated molecular signaling pathways. Experimental studies have examined its activity in peptide–DNA interaction models, chromatin-binding investigations, regulatory signaling mechanisms, and molecular pathways involved in transcriptional modulation. Its short-peptide structure makes it a valuable research tool for studies of peptide bioregulator pharmacology, chromatin-associated mechanisms, molecular signaling networks, transcription-related processes, and comparative investigations of regulatory peptide compounds.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
| Chemical Formula | C17H29N5O9 |
|---|---|
| Synonyms | Testagen bioregulator, testis-derived peptide bioregulator |
| Molar Mass | ~432 g/mol (estimated) |
| CAS Number | 77614-16-5 |
| Total Compound Content | 20 mg per vial |
| Shelf Life | 36 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
What molecular pathways has Testagen been investigated in?
Experimental studies have examined Testagen's activity in chromatin-associated regulatory systems, transcription-associated processes, peptide–DNA interaction models, and molecular signaling pathways. Proposed mechanisms involve modulation of transcriptional accessibility through interactions with chromatin-associated complexes, resulting in changes in downstream gene expression patterns. These investigations have positioned Testagen as a research tool for studying peptide-mediated regulation of transcriptional and signaling processes.
How does Testagen's proposed mechanism differ from receptor-mediated signaling pathways?
Receptor-mediated signaling pathways typically involve ligand binding to a membrane or intracellular receptor, followed by activation of downstream signaling cascades and secondary messenger systems. Testagen's proposed mechanism has been described as a direct interaction with chromatin-associated regulatory structures and transcription-related processes rather than activation of a specific receptor pathway. This distinction makes it relevant to studies investigating peptide-mediated transcriptional regulation, chromatin dynamics, and molecular regulatory mechanisms independent of classical receptor signaling.
What is the current evidence base for Testagen's molecular activity?
A: Published investigations have reported effects on transcription-associated pathways, chromatin-interaction models, peptide-mediated regulatory mechanisms, and molecular signaling networks. These findings have contributed to ongoing research into short peptide bioregulator pharmacology and the proposed role of regulatory peptides in modulating molecular processes. As with other compounds in this class, further mechanistic investigation and independent validation remain important areas of continued research.
